502 related articles for article (PubMed ID: 17380206)
1. Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model.
Dubois C; Panicot-Dubois L; Gainor JF; Furie BC; Furie B
J Clin Invest; 2007 Apr; 117(4):953-60. PubMed ID: 17380206
[TBL] [Abstract][Full Text] [Related]
2. Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis.
Vandendries ER; Hamilton JR; Coughlin SR; Furie B; Furie BC
Proc Natl Acad Sci U S A; 2007 Jan; 104(1):288-92. PubMed ID: 17190826
[TBL] [Abstract][Full Text] [Related]
3. GPIb potentiates GPVI-induced responses in human platelets.
Baker J; Griggs RK; Falati S; Poole AW
Platelets; 2004 Jun; 15(4):207-14. PubMed ID: 15203711
[TBL] [Abstract][Full Text] [Related]
4. Key role of platelet procoagulant activity in tissue factor-and collagen-dependent thrombus formation in arterioles and venules in vivo differential sensitivity to thrombin inhibition.
Kuijpers MJ; Munnix IC; Cosemans JM; Vlijmen BV; Reutelingsperger CP; Egbrink MO; Heemskerk JW
Microcirculation; 2008 May; 15(4):269-82. PubMed ID: 18464157
[TBL] [Abstract][Full Text] [Related]
5. Platelets possess and require an active protein palmitoylation pathway for agonist-mediated activation and in vivo thrombus formation.
Sim DS; Dilks JR; Flaumenhaft R
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1478-85. PubMed ID: 17303775
[TBL] [Abstract][Full Text] [Related]
6. Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI.
Penz S; Reininger AJ; Brandl R; Goyal P; Rabie T; Bernlochner I; Rother E; Goetz C; Engelmann B; Smethurst PA; Ouwehand WH; Farndale R; Nieswandt B; Siess W
FASEB J; 2005 Jun; 19(8):898-909. PubMed ID: 15923400
[TBL] [Abstract][Full Text] [Related]
7. VWF attributes--impact on thrombus formation.
Reininger AJ
Thromb Res; 2008; 122 Suppl 4():S9-13. PubMed ID: 18929523
[TBL] [Abstract][Full Text] [Related]
8. Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo.
Massberg S; Konrad I; Bültmann A; Schulz C; Münch G; Peluso M; Lorenz M; Schneider S; Besta F; Müller I; Hu B; Langer H; Kremmer E; Rudelius M; Heinzmann U; Ungerer M; Gawaz M
FASEB J; 2004 Feb; 18(2):397-9. PubMed ID: 14656994
[TBL] [Abstract][Full Text] [Related]
9. Tissue factor pathway vs. collagen pathway for in vivo platelet activation.
Furie BC; Furie B
Blood Cells Mol Dis; 2006; 36(2):135-8. PubMed ID: 16513378
[TBL] [Abstract][Full Text] [Related]
10. The glycoprotein VI-phospholipase Cgamma2 signaling pathway controls thrombus formation induced by collagen and tissue factor in vitro and in vivo.
Munnix IC; Strehl A; Kuijpers MJ; Auger JM; van der Meijden PE; van Zandvoort MA; oude Egbrink MG; Nieswandt B; Heemskerk JW
Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2673-8. PubMed ID: 16254207
[TBL] [Abstract][Full Text] [Related]
11. Role of plasma and platelet von Willebrand factor in arterial thrombogenesis and hemostasis in the pig.
André P; Brouland JP; Roussi J; Bonneau M; Pignaud G; Bal dit Sollier C; Hainaud P; Vaiman M; Drouet L
Exp Hematol; 1998 Jul; 26(7):620-6. PubMed ID: 9657137
[TBL] [Abstract][Full Text] [Related]
12. Phospholipase Cgamma2 contributes to stable thrombus formation on VWF.
Rathore V; Wang D; Newman DK; Newman PJ
FEBS Lett; 2004 Aug; 573(1-3):26-30. PubMed ID: 15327970
[TBL] [Abstract][Full Text] [Related]
13. A familial platelet function disorder associated with abnormal signalling through the glycoprotein VI pathway.
Dunkley S; Arthur JF; Evans S; Gardiner EE; Shen Y; Andrews RK
Br J Haematol; 2007 Jun; 137(6):569-77. PubMed ID: 17539777
[TBL] [Abstract][Full Text] [Related]
14. Thrombin mutant W215A/E217A acts as a platelet GPIb antagonist.
Berny MA; White TC; Tucker EI; Bush-Pelc LA; Di Cera E; Gruber A; McCarty OJ
Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):329-34. PubMed ID: 17962622
[TBL] [Abstract][Full Text] [Related]
15. Mathematical analysis of mural thrombogenesis. Concentration profiles of platelet-activating agents and effects of viscous shear flow.
Folie BJ; McIntire LV
Biophys J; 1989 Dec; 56(6):1121-41. PubMed ID: 2611327
[TBL] [Abstract][Full Text] [Related]
16. Importance of platelet phospholipase Cgamma2 signaling in arterial thrombosis as a function of lesion severity.
Nonne C; Lenain N; Hechler B; Mangin P; Cazenave JP; Gachet C; Lanza F
Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1293-8. PubMed ID: 15774906
[TBL] [Abstract][Full Text] [Related]
17. In vivo response to vascular injury in the absence of factor IX: examination in factor IX knockout mice.
Gui T; Reheman A; Funkhouser WK; Bellinger DA; Hagaman JR; Stafford DW; Monahan PE; Ni H
Thromb Res; 2007; 121(2):225-34. PubMed ID: 17490728
[TBL] [Abstract][Full Text] [Related]
18. Platelet-collagen responses: molecular basis and therapeutic promise.
Kahn ML
Semin Thromb Hemost; 2004 Aug; 30(4):419-25. PubMed ID: 15354263
[TBL] [Abstract][Full Text] [Related]
19. Cell adhesion mechanisms in platelets.
Varga-Szabo D; Pleines I; Nieswandt B
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):403-12. PubMed ID: 18174460
[TBL] [Abstract][Full Text] [Related]
20. Interactions of platelets, blood-borne tissue factor, and fibrin during arteriolar thrombus formation in vivo.
Sim D; Flaumenhaft R; Furie B; Furie B
Microcirculation; 2005; 12(3):301-11. PubMed ID: 15814438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
